HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery

CL Celum, S Delany‐Moretlwe… - Journal of the …, 2019 - Wiley Online Library
Introduction Adolescent girls and young women (AGYW) in Africa have high HIV incidence
despite scale‐up of HIV testing and HIV treatment. Placebo‐controlled trials of tenofovir …

HIV preexposure prophylaxis: a review

J Riddell, KR Amico, KH Mayer - Jama, 2018 - jamanetwork.com
Importance About 40 000 Americans and 2 million people worldwide are newly infected with
HIV each year. The combination antiretroviral regimen, tenofovir disoproxil fumarate …

[HTML][HTML] Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

DHS Tan, MW Hull, D Yoong, C Tremblay, P O'byrne… - Cmaj, 2017 - Can Med Assoc
Methods The guideline was developed by the Biomedical HIV Prevention Working Group of
the CIHR Canadian HIV Trials Network, with funding from the Canadian Institutes of Health …

[HTML][HTML] Integrating preexposure prophylaxis delivery in routine family planning clinics: a feasibility programmatic evaluation in Kenya

KK Mugwanya, J Pintye, J Kinuthia, F Abuna… - PLoS …, 2019 - journals.plos.org
Background Young women account for a disproportionate fraction of new HIV infections in
Africa and are a priority population for HIV prevention, including implementation of …

[HTML][HTML] Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of …

CA Koss, ED Charlebois, J Ayieko, D Kwarisiima… - The lancet HIV, 2020 - thelancet.com
Background Optimal strategies for pre-exposure prophylaxis (PrEP) engagement in
generalised HIV epidemics are unknown. We aimed to assess PrEP uptake and …

[HTML][HTML] Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study

A Nel, N Van Niekerk, B Van Baelen, M Malherbe… - The Lancet …, 2021 - thelancet.com
Summary Background The Ring Study, a phase 3 trial in 1959 sexually active women
(randomised 2: 1), showed a favourable safety profile and a 31% HIV-1 infection risk …

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

JM Baeten, T Palanee-Phillips, NM Mgodi, AJ Mayo… - The lancet HIV, 2021 - thelancet.com
Background Two phase 3 clinical trials showed that use of a monthly vaginal ring containing
25 mg dapivirine was well tolerated and reduced HIV-1 incidence in women by …

[HTML][HTML] HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: results from a prospective observational …

R Eakle, GB Gomez, N Naicker, R Bothma… - PLoS …, 2017 - journals.plos.org
Background Operational research is required to design delivery of pre-exposure prophylaxis
(PrEP) and early antiretroviral treatment (ART). This paper presents the primary analysis of …

PrEP rollout in Africa: status and opportunity

EM Irungu, JM Baeten - Nature medicine, 2020 - nature.com
Following recommendations by the World Health Organization in 2015, and key clinical
trials, countries in sub-Saharan Africa, the region with the highest burden of human …

Understanding demand for PrEP and early experiences of PrEP use among young adults in rural Kenya and Uganda: a qualitative study

CS Camlin, CA Koss, M Getahun, L Owino, H Itiakorit… - AIDS and Behavior, 2020 - Springer
Few studies have sought to understand factors influencing uptake and continuation of pre-
exposure prophylaxis (PrEP) among young adults in sub-Saharan Africa in the context of …